Even though SMA NBS individuals were unlikely to develop type 1 SMA due to an increased SMN2 copy number, this comparison was undertaken given that CHOP-INTEND was the age-appropriate scale used for the evaluation of these clinically silent SMA children. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.